We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Cell-cell contact-dependent secretion of large-extracellular vesicles from EFNBhigh cancer cells accelerates peritoneal dissemination

    Background

    Large non-apoptotic vesicles released from the plasma membrane protrusions are classified as large-EVs (LEVs). However, the triggers of LEV...

    Kaito Hayashi, Kurara Takagane, ... Masamitsu Tanaka in British Journal of Cancer
    Article 13 July 2024
  2. The AKT inhibitor AZD5363 elicits synthetic lethality in ARID1A-deficient gastric cancer cells via induction of pyroptosis

    Background

    Gastric cancer (GC) is a deadly disease with poor overall survival and limited therapeutic options. Genetic alterations such as mutations...

    Menghan Fang, Youfen Lin, ... **njian Lin in British Journal of Cancer
    Article 13 July 2024
  3. Introduction and impact of routine whole genome sequencing in the diagnosis and management of sarcoma

    Background

    Sarcomas are diverse neoplasms with highly variable histological appearances in which diagnosis is often challenging and management options...

    James A. Watkins, Jamie Trotman, ... Alona Sosinsky in British Journal of Cancer
    Article Open access 12 July 2024
  4. An 18-gene signature of recurrence-associated endothelial cells predicts tumor progression and castration resistance in prostate cancer

    Background

    The prognostic and therapeutic implications of endothelial cells (ECs) heterogeneity in prostate cancer (PCa) are poorly understood.

    ...
    Bing-Biao Lin, Qingqing Huang, ... Jun Pang in British Journal of Cancer
    Article Open access 12 July 2024
  5. Presence of Fusobacterium nucleatum in relation to patient survival and an acidic environment in oesophagogastric junction and gastric cancers

    Background

    Fusobacterium nucleatum inhabits the oral cavity and affects the progression of gastrointestinal cancer. Our prior findings link F....

    Yoshihiro Hara, Yoshifumi Baba, ... Hideo Baba in British Journal of Cancer
    Article 12 July 2024
  6. Establishment of a trastuzumab-resistant extramammary Paget disease model: loss of PTEN as a potential mechanism

    Background/objectives

    Extramammary Paget disease (EMPD) is a rare, cutaneous intraepithelial adenocarcinoma typically treated with wide local...

    Che-Yuan Hsu, Teruki Yanagi, ... Hideyuki Ujiie in British Journal of Cancer
    Article 10 July 2024
  7. Evolution at Spike protein position 519 in SARS-CoV-2 facilitated adaptation to humans

    As the COVID-19 pandemic enters its fourth year, the pursuit of identifying a progenitor virus to SARS-CoV-2 and understanding the mechanism of its...

    C. Cereghino, K. Michalak, ... P. Michalak in npj Viruses
    Article Open access 09 July 2024
  8. Invasive recurrence after breast conserving treatment of ductal carcinoma in situ of the breast in the Netherlands: time trends and the association with tumour grade

    Background

    The first aim of this study was to examine trends in the risk of ipsilateral invasive breast cancer (iIBC) after breast-conserving surgery...

    Rebecca L. O’Leary, Lucien E. M. Duijm, ... Adri C. Voogd in British Journal of Cancer
    Article 09 July 2024
  9. “Living with a question mark”: psychosocial experience of Portuguese young adults at risk for hereditary amyloid transthyretin amyloidosis with polyneuropathy

    This study is the first to explore the psychosocial experience of young Portuguese adults at genetic risk for hereditary amyloid transthyretin...

    José D. Pereira, Catarina Costa, ... Álvaro Mendes in Journal of Community Genetics
    Article Open access 08 July 2024
  10. Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology – an analysis of the closed cohorts of a multicentre prospective study

    Background

    Therapeutic drug monitoring (TDM) – performing dose adjustments based on measured drug levels and established pharmacokinetic (PK) targets...

    Maud B. A. van der Kleij, Niels A. D. Guchelaar, ... Neeltje Steeghs in British Journal of Cancer
    Article Open access 06 July 2024
  11. Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study

    Importance

    Intra-arterial therapies(IATs) are promising options for unresectable hepatocellular carcinoma(HCC). Stratifying the prognostic risk before...

    Chao An, Ran Wei, ... Jianjun Han in British Journal of Cancer
    Article 06 July 2024
  12. PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers

    Background

    Combining PARP inhibitors (PARPis) with immune checkpoint inhibitors may improve clinical outcomes in selected cancers. We evaluated...

    Rebecca Kristeleit, Alexandra Leary, ... Linda Mileshkin in British Journal of Cancer
    Article Open access 06 July 2024
  13. HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer

    Background

    Resistance to chemotherapy is a major problem in the treatment of patients with triple-negative breast cancer (TNBC). Preclinical data...

    Andrej Besse, Lenka Sedlarikova, ... Lenka Besse in British Journal of Cancer
    Article Open access 05 July 2024
  14. Metabolic adaptations in prostate cancer

    Prostate cancer is one of the most commonly diagnosed cancers in men and is a major cause of cancer-related deaths worldwide. Among the molecular...

    Mikel Pujana-Vaquerizo, Laura Bozal-Basterra, Arkaitz Carracedo in British Journal of Cancer
    Article Open access 05 July 2024
  15. Cancer cell extravasation requires iplectin-mediated delivery of MT1-MMP at invadopodia

    Background

    Invadopodia facilitate cancer cell extravasation, but the molecular mechanism whereby invadopodia-specific proteases such as MT1-MMP are...

    Olivia R. Grafinger, John J. Hayward, ... Hon S. Leong in British Journal of Cancer
    Article 05 July 2024
  16. ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors

    Purpose

    PARP inhibitors (PARPi) are effective in homologous recombination repair (HRR) defective (HRD) cancers. To (re)sensitise HRR proficient (HRP)...

    Hannah L. Smith, Elaine Willmore, ... Nicola J. Curtin in British Journal of Cancer
    Article Open access 04 July 2024
  17. Efficacy of a nurse-led sexual rehabilitation intervention for women with gynaecological cancers receiving radiotherapy: results of a randomised trial

    Background

    The multicentre randomised SPARC trial evaluated the efficacy of a nurse-led sexual rehabilitation intervention on sexual functioning,...

    Isabelle Suvaal, Susanna B. Hummel, ... Moniek M. ter Kuile in British Journal of Cancer
    Article Open access 03 July 2024
Did you find what you were looking for? Share feedback.